Cochrane · systematic review · CD009581
Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease
Zheng, GH, Liu, JP, Chu, JF, et al. · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library
HeartAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
14
current version
GRADE rated
10
No studies
4
Included studies
NR
No studies 4 · 28.6%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 2 · 14.3%High 8 · 57.1%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Xiongshao capsule (XSC) plus conventional western medicine (CWM) versus conventional western medicine (CWM) for restenosis after percutaneous coronary intervention in patients with coronary heart disease
Population: patients with restenosis after percutaneous coronary intervention in coronary heart disease
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
All‐cause death: not measured Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) | no estimate extracted | NR | No studies |
Cardiac mortality Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) | no estimate extracted | 2 studies · 190 participants | Moderate Downgraded: risk of bias |
Serious adverse events Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) | RR 0.47 [0.25, 0.9] | 1 study · 108 participants | High |
Restenosis Coronary angiography Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) | RR 0.41 [0.22, 0.75] | 2 studies · 190 participants | High |
Recurrence angina pectoris Treadmill exercise test Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) | RR 0.47 [0.3, 0.72] | 2 studies · 190 participants | Moderate Downgraded: risk of bias |
Health‐related quality of life: not measured Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) | no estimate extracted | NR | No studies |
Xiongshao capsule (XSC) plus conventional western medicine (CWM) versus conventional western medicine (CWM) plus placebo for restenosis after percutaneous coronary intervention in patients with coronary heart disease
Population: patients with restenosis after percutaneous coronary intervention in coronary heart disease
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
All‐cause death: not measured Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) plus placebo | no estimate extracted | NR | No studies |
Cardiac mortality Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) plus placebo | no estimate extracted | 2 studies · 432 participants | High |
Serious adverse events Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) plus placebo | RR 0.45 [0.28, 0.7] | 2 studies · 432 participants | High |
Restenosis Coronary angiography Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) plus placebo | RR 0.52 [0.33, 0.8] | 2 studies · 432 participants | High |
Recurrence angina pectoris with 1 month Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) plus placebo | RR 0.31 [0.1, 0.92] | 1 study · 314 participants | High |
Recurrence angina pectoris with 3 months' Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) plus placebo | RR 0.37 [0.19, 0.71] | 1 study · 314 participants | High |
Recurrence angina pectoris with 6 months' Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) plus placebo | RR 0.26 [0.18, 0.38] | 2 studies · 432 participants | High |
Health‐related quality of life: not measured Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) plus placebo | no estimate extracted | NR | No studies |